GlassScriptPhysician profile
John R Koethe
NPI 1831235845
$91,212.21
in general payments reported to CMS, 2019-2025
6 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,440 · 2020: $19K · 2021: $9,948 · 2022: $18K · 2023: $16K · 2024: $9,127 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $12K · Honoraria: $1,500 · Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,575.00 |
| Travel and Lodging | $11,639.92 |
| Honoraria | $1,500.00 |
| Food and Beverage | $906.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $44,565.46 | 2020-2025 | Delstrigo |
| Gilead Sciences, INC. | $22,765.37 | 2021-2025 | |
| Theratechnologies INC. | $12,473.38 | 2019-2024 | |
| Janssen Products, LP | $7,848.00 | 2022 | |
| Viiv Healthcare Company | $2,760.00 | 2020 | |
| Janssen Scientific Affairs, LLC | $800.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Koethe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.